tiprankstipranks
Trending News
More News >
Arovella Therapeutics Limited (AU:ALA)
ASX:ALA
Australian Market
Advertisement

Arovella Therapeutics Limited (ALA) Income Statement

Compare
14 Followers

Arovella Therapeutics Limited Income Statement

Last quarter (Q4 2025), Arovella Therapeutics Limited's total revenue was AU$415.00, a decrease of -90.24% from the same quarter last year. In Q4, Arovella Therapeutics Limited's net income was AU$-3.02M. See Arovella Therapeutics Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
AU$ 136.00KAU$ 17.00KAU$ 405.90KAU$ 295.81KAU$ 257.35K
Gross Profit
AU$ 136.00KAU$ -25.98KAU$ -3.00MAU$ 88.75KAU$ 34.60K
Operating Expenses
AU$ 11.34MAU$ 10.79MAU$ 6.68MAU$ 5.23MAU$ 3.74M
Depreciation and Amortization
AU$ 107.29KAU$ 42.98KAU$ 837.18KAU$ 551.49KAU$ 652.18K
EBITDA
AU$ -11.10MAU$ -10.63MAU$ -10.37MAU$ -7.87MAU$ -4.99M
Operating Income
AU$ -11.20MAU$ -10.81MAU$ -9.68MAU$ -7.59MAU$ -2.99M
Other Income/Expenses
AU$ 3.69MAU$ 2.07MAU$ -1.55MAU$ -1.02MAU$ -2.05M
Pretax Income
AU$ -7.51MAU$ -8.75MAU$ -11.23MAU$ -8.62MAU$ -5.05M
Net Income
AU$ -7.51MAU$ -8.75MAU$ -10.18MAU$ -8.62MAU$ -5.05M
Per Share Metrics
Basic EPS
AU$ -0.01AU$ -0.01AU$ -0.01AU$ -0.02AU$ -0.02
Diluted EPS
AU$ -0.01AU$ -0.01AU$ -0.01AU$ -0.02AU$ -0.02
Weighted Average Shares Outstanding
1.10B 941.42M 711.48M 549.62M 330.89M
Weighted Average Shares Outstanding (Diluted)
1.10B 941.42M 711.48M 549.62M 330.89M
Currency in AUD

Arovella Therapeutics Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis